Literature DB >> 11169739

Transcriptional regulation of alpha 2(I) collagen gene expression by fibroblast growth factor-2 in MC3T3-E1 osteoblast-like cells.

M A Fang1, C A Glackin, A Sadhu, S McDougall.   

Abstract

Fibroblast growth factor-2 (FGF-2) stimulates proliferation and inhibits differentiated function of osteoblasts by suppressing synthesis of type I collagen and other proteins. However, little is known regarding the molecular mechanisms regulating the suppressive effects of FGF-2 on type I collagen synthesis in osteoblasts. The zinc finger transcription factor Egr-1 and the basic helix-loop-helix (bHLH) family of proteins have been implicated in the regulation of genes crucial to mesodermal cell growth and differentiation. The aim of this study was to determine whether Egr-1 and TWIST might be potential transcriptional regulators of the inhibitory effects of FGF-2 on alpha2(I) collagen expression in MC3T3-E1 osteoblasts which undergo a developmental sequence in vitro. Upon treatment of undifferentiated MC3T3-E1 cells with 1 nM FGF-2, Egr-1 mRNA increased with the effect maximal after 30-60 min. TWIST mRNA also increased with the effect maximal at 2 h. We analyzed the transcriptional control of alpha2(I) collagen gene expression by FGF-2 by transient transfection of an alpha2(I) collagen-luciferase construct (pH5) into undifferentiated MC3T3-E1 cells. The activity of the pH5 luciferase promoter decreased in a dose-dependent manner following treatment with.01 and 1 nM FGF-2. We identified putative Egr-1 and TWIST recognition sequences in the proximal region of the promoter for the murine alpha2(I) collagen gene and a putative Egr-1 site in the 5' region of the murine TWIST promoter. In gel mobility shift assays, potential Egr-1 response elements in the 5' region of the murine TWIST and alpha2(I) collagen genes demonstrated specific Egr-1 binding activity with bFGF-treated nuclear extracts obtained from MC3T3-E1 cells. These results indicate that Egr-1 and TWIST are expressed in undifferentiated MC3T3-E1 osteoblast-like cells following treatment with FGF-2 and they may be potential transcriptional regulators of FGF-2s negative effects on alpha2(I) collagen gene expression. J. Cell. Biochem. 80:550-559, 2001. Published 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11169739

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  8 in total

Review 1.  A strategy for identifying osteoporosis risk genes.

Authors:  David Rowe; Alexander Lichtler
Journal:  Endocrine       Date:  2002-02       Impact factor: 3.633

Review 2.  Endocrine functions of bone in mineral metabolism regulation.

Authors:  L Darryl Quarles
Journal:  J Clin Invest       Date:  2008-12-01       Impact factor: 14.808

Review 3.  Evidence for FGF23 involvement in a bone-kidney axis regulating bone mineralization and systemic phosphate and vitamin D homeostasis.

Authors:  Aline Martin; L Darryl Quarles
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

Review 4.  Regulation and function of the FGF23/klotho endocrine pathways.

Authors:  Aline Martin; Valentin David; L Darryl Quarles
Journal:  Physiol Rev       Date:  2012-01       Impact factor: 37.312

5.  Extracellular ATP stimulates the early growth response protein 1 (Egr-1) via a protein kinase C-dependent pathway in the human osteoblastic HOBIT cell line.

Authors:  Alex Pines; Milena Romanello; Laura Cesaratto; Giuseppe Damante; Luigi Moro; Paola D'andrea; Gianluca Tell
Journal:  Biochem J       Date:  2003-08-01       Impact factor: 3.857

6.  Twist1 homodimers enhance FGF responsiveness of the cranial sutures and promote suture closure.

Authors:  Jeannette Connerney; Viktoria Andreeva; Yael Leshem; Miguel A Mercado; Karen Dowell; Xuehei Yang; Volkhard Lindner; Robert E Friesel; Douglas B Spicer
Journal:  Dev Biol       Date:  2008-04-08       Impact factor: 3.582

7.  Lysyl oxidase propeptide inhibits FGF-2-induced signaling and proliferation of osteoblasts.

Authors:  Siddharth R Vora; Amitha H Palamakumbura; Maria Mitsi; Ying Guo; Nicole Pischon; Matthew A Nugent; Philip C Trackman
Journal:  J Biol Chem       Date:  2010-01-04       Impact factor: 5.157

8.  Vascularization converts the lineage fate of bone mesenchymal stem cells to endothelial cells in tissue-engineered bone grafts by modulating FGF2-RhoA/ROCK signaling.

Authors:  Donglin Li; Pengzhen Cheng; Huijie Jiang; Tianqing Cao; Jimeng Wang; Yi Gao; Yangjing Lin; Chunmei Wang; Shuaishuai Zhang; Junqin Li; Bin Liu; Yue Song; Liu Yang; Guoxian Pei
Journal:  Cell Death Dis       Date:  2018-09-20       Impact factor: 8.469

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.